ETEFCA Trademark

Trademark Overview


On Tuesday, March 6, 2018, a trademark application was filed for ETEFCA with the United States Patent and Trademark Office. The USPTO has given the ETEFCA trademark a serial number of 87822852. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Thursday, March 12, 2020. This trademark is owned by Eli Lilly and Company. The ETEFCA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents a...
etefca

General Information


Serial Number87822852
Word MarkETEFCA
Filing DateTuesday, March 6, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateThursday, March 12, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 17, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 13, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, May 11, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 11, 2020ABANDONMENT - NO USE STATEMENT FILED
Friday, July 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 24, 2019EXTENSION 2 GRANTED
Wednesday, July 24, 2019EXTENSION 2 FILED
Wednesday, July 24, 2019TEAS EXTENSION RECEIVED
Thursday, February 7, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 6, 2019EXTENSION 1 GRANTED
Wednesday, January 30, 2019EXTENSION 1 FILED
Wednesday, February 6, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 30, 2019TEAS EXTENSION RECEIVED
Tuesday, September 11, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 17, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 17, 2018PUBLISHED FOR OPPOSITION
Wednesday, June 27, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 13, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 12, 2018ASSIGNED TO EXAMINER
Tuesday, March 13, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 9, 2018NEW APPLICATION ENTERED IN TRAM